Once-Daily SPN-812 200 and 400 mg in the treatment of ADHD in School-aged Children: A Phase III Randomized, Controlled Trial
Titel:
Once-Daily SPN-812 200 and 400 mg in the treatment of ADHD in School-aged Children: A Phase III Randomized, Controlled Trial
Auteur:
Nasser, Azmi Liranso, Tesfaye Adewole, Toyin Fry, Nicholas Hull, Joseph T. Chowdhry, Fatima Busse, Gregory D. Melyan, Zare Cutler, Andrew J. Findling, Robert L. Schwabe, Stefan